サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/13 | 975 | 1,016 | 952 | 1,009 | +34 | +3.5% | 1,116,500 |
| 2024/08/09 | 1,000 | 1,012 | 945 | 975 | -26 | -2.6% | 1,462,700 |
| 2024/08/08 | 1,001 | 1,061 | 988 | 1,001 | -12 | -1.2% | 1,400,900 |
| 2024/08/07 | 980 | 1,054 | 969 | 1,013 | +38 | +3.9% | 2,474,000 |
| 2024/08/06 | 922 | 975 | 902 | 975 | +150 | +18.2% | 2,449,600 |
| 2024/08/05 | 943 | 973 | 805 | 825 | -193 | -19% | 3,346,000 |
| 2024/08/02 | 1,020 | 1,096 | 988 | 1,018 | -92 | -8.3% | 3,421,500 |
| 2024/08/01 | 1,086 | 1,220 | 1,072 | 1,110 | -6 | -0.5% | 8,629,100 |
| 2024/07/31 | 978 | 1,116 | 960 | 1,116 | +150 | +15.5% | 7,602,200 |
| 2024/07/30 | 961 | 1,020 | 933 | 966 | -10 | -1% | 1,872,700 |
| 2024/07/29 | 1,217 | 1,225 | 966 | 976 | -65 | -6.2% | 6,965,200 |
| 2024/07/26 | 1,041 | 1,041 | 1,041 | 1,041 | +150 | +16.8% | 110,000 |
| 2024/07/25 | 904 | 920 | 866 | 891 | -41 | -4.4% | 1,572,600 |
| 2024/07/24 | 974 | 998 | 932 | 932 | -57 | -5.8% | 1,135,700 |
| 2024/07/23 | 1,006 | 1,035 | 930 | 989 | -30 | -2.9% | 2,229,300 |
| 2024/07/22 | 1,032 | 1,057 | 1,012 | 1,019 | -42 | -4% | 1,179,900 |
| 2024/07/19 | 1,130 | 1,152 | 1,047 | 1,061 | -76 | -6.7% | 1,657,600 |
| 2024/07/18 | 1,112 | 1,170 | 1,105 | 1,137 | ±0 | ±0% | 1,690,300 |
| 2024/07/17 | 1,116 | 1,164 | 1,105 | 1,137 | +19 | +1.7% | 2,067,900 |
| 2024/07/16 | 1,046 | 1,120 | 1,038 | 1,118 | +66 | +6.3% | 1,396,700 |
| 2024/07/12 | 1,122 | 1,124 | 1,043 | 1,052 | -46 | -4.2% | 1,657,400 |
| 2024/07/11 | 1,094 | 1,147 | 1,066 | 1,098 | +10 | +0.9% | 3,572,000 |
| 2024/07/10 | 1,029 | 1,099 | 1,022 | 1,088 | +74 | +7.3% | 3,291,000 |
| 2024/07/09 | 1,012 | 1,064 | 1,005 | 1,014 | -14 | -1.4% | 2,174,400 |
| 2024/07/08 | 980 | 1,054 | 978 | 1,028 | +27 | +2.7% | 3,183,900 |
| 2024/07/05 | 1,133 | 1,137 | 991 | 1,001 | -79 | -7.3% | 5,559,900 |
| 2024/07/04 | 1,043 | 1,140 | 1,033 | 1,080 | +48 | +4.7% | 6,235,400 |
| 2024/07/03 | 1,100 | 1,141 | 1,016 | 1,032 | -22 | -2.1% | 4,128,200 |
| 2024/07/02 | 1,138 | 1,156 | 1,000 | 1,054 | -164 | -13.5% | 8,125,200 |
| 2024/07/01 | 1,258 | 1,368 | 1,218 | 1,218 | -100 | -7.6% | 9,267,400 |
| 2024/06/28 | 1,400 | 1,489 | 1,274 | 1,318 | -80 | -5.7% | 25,009,900 |
| 2024/06/27 | 1,248 | 1,398 | 1,104 | 1,398 | +300 | +27.3% | 12,834,400 |
| 2024/06/26 | 1,098 | 1,098 | 1,098 | 1,098 | +150 | +15.8% | 316,700 |
| 2024/06/25 | 843 | 948 | 831 | 948 | +150 | +18.8% | 7,970,500 |
| 2024/06/24 | 688 | 798 | 687 | 798 | +100 | +14.3% | 12,206,700 |
| 2024/06/21 | 758 | 821 | 698 | 698 | -150 | -17.7% | 16,945,800 |
| 2024/06/20 | 848 | 848 | 848 | 848 | -150 | -15% | 275,500 |
| 2024/06/19 | 1,035 | 1,123 | 941 | 998 | -9 | -0.9% | 13,065,700 |
| 2024/06/18 | 1,120 | 1,273 | 979 | 1,007 | -143 | -12.4% | 27,868,600 |
| 2024/06/17 | 950 | 1,210 | 937 | 1,150 | +375 | +48.4% | 31,981,800 |
| 2024/06/14 | 775 | 775 | 775 | 775 | +100 | +14.8% | 200,300 |
| 2024/06/13 | 675 | 675 | 675 | 675 | +100 | +17.4% | 257,100 |
| 2024/06/12 | 489 | 575 | 487 | 575 | +80 | +16.2% | 873,200 |
| 2024/06/11 | 489 | 510 | 481 | 495 | +14 | +2.9% | 650,200 |
| 2024/06/10 | 484 | 490 | 477 | 481 | -8 | -1.6% | 404,300 |
| 2024/06/07 | 475 | 492 | 475 | 489 | +16 | +3.4% | 351,400 |
| 2024/06/06 | 481 | 484 | 468 | 473 | -3 | -0.6% | 333,700 |
| 2024/06/05 | 491 | 491 | 472 | 476 | -18 | -3.6% | 572,400 |
| 2024/06/04 | 499 | 506 | 491 | 494 | -5 | -1% | 383,100 |
| 2024/06/03 | 505 | 513 | 499 | 499 | -7 | -1.4% | 478,700 |
251～
300
件表示中 / 2535件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 250,600円 | - | - | 0.00% | - | 116.07倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 151,600円 | +5.0% | +1.5% | 0.00% | 12.97倍 | 3.65倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 386,600円 | -6.4% | -71.8% | 4.91% | 43.06倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 297,400円 | +7.9% | -3.3% | 2.69% | 8.27倍 | 0.85倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
